Sarepta Therapeutics Inc. (NASDAQ:SRPT) said Monday that it would submit a new drug application to the U.S. Food and Drug Administration by the end of the year for its experimental treatment for a fatal degenerative disease that afflicts children. Sarepta Therapeutics Inc. (NASDAQ:SRPT) shares after opening at $34.56 moved to $39.20 on last trade day and at the end of the day closed at $38.79. Company price to sales ratio in past twelve months was calculated as 103.18 and price to cash ratio as 5.70. Sarepta Therapeutics Inc. (NASDAQ:SRPT) showed a positive weekly performance of 74.02%.
Ford Motors Company (NYSE:F) is looking forward to revive its classic Escort nameplate soon. The car was first introduced in the North American market in 1981 and touted as Ford’s first ‘world car’. The car has been widely accepted around the world until the end of its life in 2003. After 12 years of long hibernation, company has prepared to give it a new lease of life by re-launching it in a new avatar. Ford Motor Company (NYSE:F) shares advanced 0.75% in last trading session and ended the day on $16.10. F return on equity ratio is recorded as 34.20% and its return on assets is 3.60%. Ford Motor Company (NYSE:F) yearly performance is 26.67%.
General Motors (NYSE:GM) has filed a motion in a US Bankruptcy Court to enforce a bar on lawsuits related to ignition defects in cars sold before its 2009 bankruptcy as it fights a class-action lawsuit that seeks to set aside the restriction. General Motors Company (NYSE:GM) shares moved up 0.74% in last trading session and was closed at $34.23, while trading in range of $34.00 – $34.44. General Motors Company (NYSE:GM) year to date (YTD) performance is -15.50%.
Medley Capital Corporation (NYSE:MCC) announced the commencement of a registered public offering of 6,000,000 shares of its common stock. Medley Capital Corp (NYSE:MCC) weekly performance is 2.03%. On last trading day company shares ended up $13.54. Medley Capital Corp (NYSE:MCC) distance from 50-day simple moving average (SMA50) is -1.00%. Analysts mean target price for the company is $15.13.